Outcomes of light‐chain amyloidosis patients treated with first‐line bortezomib: a collaborative retrospective multicenter assessmentMoshe E. Gatt, Svetlana Trestman, Izhar Hardan et al.|European Journal Of Haematology|2015Cited by 16